Then, a focus group discussion took place among five policy makers and experts to screen, rank and reduce the 7 extracted attributes and levels that fit the influenza vaccine based on this study purpose. Four attributes were eventually selected: 1) vaccination setting; 2) appointment mode; 3) ...
3 Since 2022, the ACIP has recommended that adults aged 65 years or older preferentially receive any one of the following: quadrivalent high-dose inactivated influenza vaccine (HD-IIV4),10 quadrivalent recombinant influenza vaccine,11 or aIIV4.3,12 The safety of simultaneous administration of aI...
different influenza vaccines are given to children aged < 3 years and ≥ 3 years [13]. The vaccine given to children aged < 3 years is named the “children
vaccination status for the ACS cohort was not known. However, in the Netherlands individuals <60 years of age are only eligible for influenza vaccination if they have underlying health conditions, and assuming population-wide rates of influenza vaccine uptake in the Netherlands...
all individuals, sera was collected after enrollment in the autumn of 2009 and again each subsequent autumn, and each spring for at least 25% of participants. Participants were invited annually to continue enrollment. Individuals reported receipt of the influenza vaccine outside of the trial ...
Full vaccination status was defined as 2 doses, and partial status was defined as having 1 dose of an approved vaccine, which corresponded to the established provincial criteria during the study period that was before the availability of third and fourth booster doses. Comorbidities were identified...
293 T cells (ATCC, CRL-3216) and secreted mAbs were subjected to ELISA screening. The Fluvirin seasonal influenza vaccine (Novartis) contained the B/Brisbane/60/2008 strain of IBV. Recombinant soluble HA protein from the B/Hong Kong/8/1973 strain was generated with synthesized coding DNA ...
(HLA-I) on the surface of virus-infected cells. As such, new T cell based influenza vaccine approaches aim to fully utilize the potential of cross-protective CD8+T cells16. Indeed novel mRNA vaccine platforms have successfully induced influenza-specific CD8+T cell responses in mice and ferrets...
4255-4261, 10.1016/j.vaccine.2017.06.013 View PDFView articleView in ScopusGoogle Scholar 12 E.E. Hornick, Z.R. Zacharias, K.L. Legge Kinetics and phenotype of the CD4 T cell response to influenza virus infections Front. Immunol., 10 (2019), Article 2351, 10.3389/fimmu.2019.02351 View ...
mRNA-1083 resulted in geometric mean titer (GMT) ratios >1.0 relative to Fluarix in adults 50-64 years of age, for all four influenza vaccine strains. GMT ratios for mRNA-1083 relative to Fluzone HD in adults 65-79 were a...